c-Rel: A pioneer in directing regulatory T-cell lineage commitment?

European Journal of Immunology

Volumn 40, Issue 3, 2010, Pages 664-667

  Hori, Shohei ^a  

^a RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

Cell differentiation; Gene regulation; NF B pathway; Regulatory T cells; Transcription factors

Indexed keywords

CD28 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR REL;

ANIMAL CELL; ANIMAL EXPERIMENT; CELL DIFFERENTIATION; DNA SEQUENCE; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; NOTE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TRANSCRIPTION REGULATION;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; PROTO-ONCOGENE PROTEINS C-REL; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 77749245810     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201040372     Document Type: Note

References (25)

1. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. and Toda, M., Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 1995. 155: 1151-1164.
2. Fontenot, J. D., Gavin, M. A. and Rudensky, A. Y., Foxp3 programs the development and function of CD4+CD25+regulatory T cells. Nat. Immunol. 2003. 4: 330-336.
3. Khattri, R., Cox, T., Yasayko, S. A. and Ramsdell, F., An essential role for Scurfin in CD4+CD25+T regulatory cells. Nat. Immunol. 2003. 4: 337-342.
4. Hori, S., Nomura, T. and Sakaguchi, S., Control of regulatory T cell development by the transcription factor Foxp3. Science 2003. 299: 1057-1061.
5. Josefowicz, S. Z. and Rudensky, A., Control of regulatory T cell lineage commitment and maintenance. Immunity 2009. 30: 616-625.
6. Curotto de Lafaille, M. A. and Lafaille, J. J., Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor? Immunity 2009. 30: 626-635.
7. Feuerer, M., Hill, J. A., Mathis, D. and Benoist, C., Foxp3+regulatory T cells: differentiation, specification, subphenotypes. Nat. Immunol. 2009. 10: 689-695.
8. Huehn, J., Polansky, J. K. and Hamann, A., Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? Nat. Rev. Immunol. 2009. 9: 83-89.
9. Komatsu, N., Mariotti-Ferrandiz, M. E., Wang, Y., Malissen, B., Waldmann, H. and Hori, S., Heterogeneity of natural Foxp3+T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc. Natl. Acad. Sci. USA 2009. 106: 1903-1908.
10. Hori, S., Rethinking the molecular definition of regulatory T cells. Eur. J. Immunol. 2008. 38: 928-930.
11. Schmidt-Supprian, M., Courtois, G., Tian, J., Coyle, A. J., Israel, A., Rajewsky, K. and Pasparakis, M., Mature T cells depend on signaling through the IKK complex. Immunity 2003. 19: 377-389.
12. Schmidt-Supprian, M., Tian, J., Grant, E. P., Pasparakis, M., Maehr, R., Ovaa, H., Ploegh, H. L. et al., Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc. Natl. Acad. Sci. USA 2004. 101: 4566-4571.
13. Gupta, S., Manicassamy, S., Vasu, C., Kumar, A., Shang, W. and Sun, Z., Differential requirement of PKC-theta in the development and function of natural regulatory T cells. Mol. Immunol. 2008. 46: 213-224.
14. Barnes, M. J., Krebs, P., Harris, N., Eidenschenk, C., Gonzalez-Quintial, R., Arnold, C. N., Crozat, K. et al., Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery. PLoS Biol. 2009. 7: e51.
15. Molinero, L. L., Yang, J., Gajewski, T., Abraham, C., Farrar, M. A. and Alegre, M. L., CARMA1 controls an early checkpoint in the thymic development of FoxP3+regulatory T cells. J. Immunol. 2009. 182: 6736-6743.
16. Medoff, B. D., Sandall, B. P., Landry, A., Nagahama, K., Mizoguchi, A., Luster, A. D. and Xavier, R. J., Differential requirement for CARMA1 in agonist-selected T-cell development. Eur. J. Immunol. 2009. 39: 78-84.
17. Deenick, E. K., Elford, A. R., Pellegrini, M., Hall, H., Mak, T.W. and Ohashi, P. S., c-Rel but not NF-kappaB1 is important for T regulatory cell development. Eur. J. Immunol. 2010. 40: DOI: 10.1002/eji. 201040298.
18. Visekruna, A., Huber, M., Hellhund, A., Bothur, E., Reinhard, K., Bollig, N., Schmidt, N. et al., c-Rel is crucial for the induction of Foxp3(+) regulatory CD4(+) T cells but not T(H)17 cells. Eur. J. Immunol. 2010. 40: DOI: 10.1002/ eji.200940260.
19. Isomura, I., Palmer, S., Grumont, R. J., Bunting, K., Hoyne, G., Wilkinson, N., Banerjee, A. et al., c-Rel is required for the development of thymic Foxp3+CD4 regulatory T cells. J. Exp. Med. 2009. 206: 3001-3014.
20. Long, M., Park, S. G., Strickland, I., Hayden, M. S. and Ghosh, S., Nuclear factor-kappaB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor. Immunity 2009. 31: 921-931.
21. Ruan, Q., Kameswaran, V., Tone, Y., Li, L., Liou, H. C., Greene, M. I., Tone, M. and Chen, Y. H., Development of Foxp3(+) regulatory T cells is driven by the c-Rel enhanceosome. Immunity 2009. 31: 932-940.
22. Zheng, Y., Josefowicz, S., Chaudhry, A., Peng, X. P., Forbush, K. and Rudensky, A. Y., Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010. 463: 808-812.
23. Zheng, Y., Vig, M., Lyons, J., Van Parijs, L. and Beg, A. A., Combined deficiency of p50 and cRel in CD4+T cells reveals an essential requirement for nuclear factor kappaB in regulating mature T cell survival and in vivo function. J. Exp. Med. 2003. 197: 861-874.
24. Zhou, L., Lopes, J. E., Chong, M. M., Ivanov, II., Min, R., Victora, G. D., Shen, Y. et al., TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 2008. 453: 236-240.
25. Weaver, C. T. and Hatton, R. D., Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective. Nat. Rev. Immunol. 2009. 9: 883-889.